SNY
Sanofi Sponsored ADR · NASDAQ
- Sector Commercial Services
- Industry Miscellaneous Commercial Services
- Website anofi.com
- Employees(FY) 91573
- ISIN US80105N1054
Performance
+0.98%
1W
+4.91%
1M
+5.33%
3M
+9.57%
6M
-0.32%
YTD
-7.29%
1Y
Profile
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Investment Analysis Report: Sanofi (SNY)
Overview
Sanofi (SNY) is a major player in the pharmaceutical industry, with a market cap of $115.86 billion. The company operates in the Health Technology sector and the Pharmaceuticals: Major industry. In this report, we will conduct a comprehensive analysis of Sanofi's financial statements over the pas...
Technical Analysis of SNY 2024-05-03
Overview:
In analyzing the technical indicators for SNY over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key factors, we aim to offer valuable insights and predictions for potential investo...
Recent News & Updates
- 2024-05-06 14:01
- 2024-05-06 11:59
- 2024-05-06 10:59
- 2024-05-06 02:06
- 2024-05-03 10:15
- 2024-05-03 00:23
- 2024-05-02 23:59
Q1 2024 Kymera Therapeutics Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-05-02 10:01
- 2024-05-02 07:15
- 2024-05-02 01:00
- 2024-05-01 13:00
- 2024-04-30 13:22
Sanofi (NASDAQ:SNY) Q1 2024 Earnings Call Transcript(Insider Monkey)
- 2024-04-30 12:00
Press Release: Annual General Meeting of April 30, 2024(GlobeNewswire)
- 2024-04-30 00:00
Press Release: Annual General Meeting of April 30, 2024(Globenewswire)
- 2024-04-29 02:23
Analyst Report: Sanofi(Morningstar Research)
- 2024-04-26 11:34
- 2024-04-25 17:52
Analyst Report: Sanofi(Yahoo Finance)
- 2024-04-25 13:45
Sanofi (SNY) Q1 2024 Earnings Call Transcript(Motley Fool)
- 2024-04-25 11:34
20 Fastest Growing Health Tech Companies in the World(Insider Monkey)
- 2024-04-25 11:19
- 2024-04-25 10:30
AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge(Investor's Business Daily)
- 2024-04-25 09:01
- 2024-04-25 08:15
- 2024-04-25 07:31
AstraZeneca, Sanofi Jump On First-Quarter Earnings; Bristol Myers Lags(Investor's Business Daily)
- 2024-04-25 03:25
Sanofi Sales, Profit Beat Expectations(The Wall Street Journal)
- 2024-04-25 02:05
- 2024-04-25 01:32
- 2024-04-25 01:30
- 2024-04-25 01:30
- 2024-04-25 01:30
CureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript(Insidermonkey)
Page 1 of 10
previousnext